If you like this story please SHARE!

Medicinal cannabis trial for Tourette syndrome patients at Wesley

AN AUSTRALIAN-first study of medicinal cannabis as a treatment for the debilitating neurological condition Tourette syndrome is set to be launched in Brisbane.

Wesley Medical Research Institute neuropsychiatrist Philip Mosley will trial a medicinal cannabis product in 24 adults with severe Tourette syndrome – a disorder which begins in childhood and is characterised by involuntary movements and vocalisations.